Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2005 / Cilt: 39 - Sayı: 2

A comparsion between the effects of calcipotriol lotion, momethasone furoate lotion and their combinations for the treatment of scalp psoriasis

Kalsipotriol losyon, mometazon furoat losyon ve kombinasyonlarının saçlı deri psoriazisi tedavisindeki etkinliğinin karşılaştırılması

Pages
109–114
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: At the end of the study extent score, itching score, total clinical sign score and psoriasis scalp severity index were found to be decreased in all of the groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Topical corticosteroids and calcipotriol lotion are the most preferred agents for the treatment of scalp psoriasis.
📊
Key Findings & Data:Since combination treatments increase effectiveness and decrease side effects, they are usually preferred for treatment of scalp psoriasis.
💡
Conclusion & Impact:Results: At the end of the study extent score, itching score, total clinical sign score and psoriasis scalp severity index were found to be decreased in all of the groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Topical corticosteroids and calcipotriol lotion are the most preferred agents for the treatment of scalp psoriasis. Since combination treatments increase effectiveness and decrease side effects, they are usually preferred for treatment of scalp psoriasis. The aim of our study was to compare the effectiveness and side effects of momethasone furoate lotion, calcipotriol lotion and combination of these two agents for the scalp psoriasis. Materials and Methods: Forty-five patients who had mild to moderate scalp psoriasis were randomly divided to three groups. Calcipotriol lotion for the first group, momethasone furoate lotion for the second group and combination of these two agents for the third group were used for four weeks. Results: At the end of the study extent score, itching score, total clinical sign score and psoriasis scalp severity index were found to be decreased in all of the groups (p

Özet

Saçlı deri psoriazisi tedavisinde topikal kortikosteroidler ve kalsipotriol losyon en çok tercih edilen ajanlardır. Genellikle etkinliği arttırmak ve yan etkileri azaltmak için kombinasyon tedavileri kullanılmaktadır. Çalışmamızda kalsipotriol losyon, mometazon furoat losyon ve her iki ajanın kombinasyonunun saçlı deri psoriazisindeki etki ve yan etkilerini karşılaştırmayı amaçladık. Hafif ve orta şiddetteki saçlı deri psoriazisi olan 45 hasta randomize olarak üç eşit gruba ayrıldı. Birinci gruba kalsipotriol losyon, ikinci gruba mometazon furoat losyon ve üçüncü gruba her iki losyon 4 hafta boyunca uygulattırıldı. Çalışma sonunda, her üç grupta da yayılım skorları, kaşıntı skorları, toplam klinik belirti skorları ve psoriazis saçlı deri şiddet indeksi değerlerinde başlangıca göre azalma kaydedildi (p

🔖

Cite This Article

YILMAZ, H., TURANLI, A. Y., CANTÜRK, T., ŞENTÜRK, N., AYDIN, F. (2022). A comparsion between the effects of calcipotriol lotion, momethasone furoate lotion and their combinations for the treatment of scalp psoriasis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 39 - Sayı: 2, 109–114. https://ajindex.com/articles/622216

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Green C, Ganpule M, Harris D, et al: Comparative efects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp. Br J Dermatol 1994;130(4):483-487
  2. Van de Kerkhof PC, Fransen MEJ: Psoriasis of the scalp: diagnosis and management. Am J Clin Dermatol 2001;2(3):159-165
  3. Prakash A, Benfield P: Topical mometasone. a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs 1998;55(1):145-163
  4. Van de Kerkof PC: Psoriasis. Dermatology. Ed. Bolognia JL, Jorizzo JL, Rapini RP. 1st ed. London, Mosby 2003;125-149
  5. Koo J: Vitamin D and scalp psoriasis. Cutis 2002;70(5 Suppl):21-24
  6. Klaber MR, Hutchinson PE, Pedvis-Leftick A: Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 1 7-valerate solution (1 mg/ml) in the treatment of scalp psoriasis. Br J Dermatol 1994;131(5):678-683
  7. Thaci D, Daiber W, Boehncke WH, Kaufmann R: Calcipotriol solution for the treatment of scalp psoriasis: eva¬luation of efficacy, safety and acceptance in 3,396 patients. Dermatology 2001;203(2):153-156
  8. Lebwohl M: Vitamin D and topical therapy. Cutis 2002;70(5Suppl):5-8
  9. Van de Kerkhof PC, Green C, Hamberg KJ, et al: Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis. Dermatology 2002;204(3):214-221
  10. Patel B, Siskin S, Krazmien BA.Lebwohl M: Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol 1998:38:1010-1011.